Thomas Borody
Topelia Therpeutics · Big Corona Ltd. · Centre for Digestive Diseases
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Borody as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:09 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04482686 · Trial of Combination Therapy to Treat COVID-19 InfectionProgenaBiome · completed · COVID, Covid-19, Corona Virus Infection · study director
- Ph2NCT04459702 · A Study of Combination Therapies to Treat COVID-19 InfectionProgenaBiome · withdrawn · COVID, COVID-19, Corona Virus Infection · principal investigator
- Ph2NCT03618108 · Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart DiseaseCadrock Pty. Ltd. · terminated · Coronary Heart Disease, Chlamydophila Pneumoniae Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:09 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- 1,052 citationsRCR 38.9
- Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.Microbiome · 20171,029 citationsRCR 41.9
- Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.Gastroenterology · 2019420 citationsRCR 17.6
- Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.Lancet Gastroenterol Hepatol · 2022263 citationsRCR 20.1
- 222 citationsRCR 8.3
- Donor Recruitment for Fecal Microbiota Transplantation.Inflamm Bowel Dis · 2015115 citationsRCR 4.0
- 106 citationsRCR 4.2
- Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.Aliment Pharmacol Ther · 200380 citationsRCR 2.5
- Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer.Am J Gastroenterol · 199477 citationsRCR 3.9
- Effects of morphine and atropine on motility and transit in the human ileum.Gastroenterology · 198575 citationsRCR 3.7